 |
|
|
| |
Sofosbuvir Plus Ribavirin For HCV Genotype 1-3 Infection in HIV Co-infected Patients (PHOTON-1)
|
| |
| |
Reported by Jules Levin
APASL 2014, Brisbane, Australia
Douglas Dieterich1, Susanna Naggie2, Jacob Lalezari3, W. Jeffrey Fessel4, Karam Mounzer5, Margaret Shuhart6, Annie Luetkemeyer7, David Asmuth8, Anuj Gaggar9, Liyun Ni9, Evguenia Svarovskaia9, Bill Symonds9, John McHutchison9,, Maribel Rodriguez-Torres10,Mark Sulkowski11
1Mount Sinai School of Medicine, New York, NY, USA; 2Duke Clinical Research Institute, Durham, NC, USA; 3Quest Clinical Research, San Francisco, CA, USA; 4Kaiser Permanente, San Francisco, CA; 5Philadelphia FIGHT, Philadelphia, PA, USA; 6Harborview Medical Center, University of Washington, Seattle, WA, USA; 7San Francisco General Hospital, University of California, San Francisco, CA; 8University of California Davis Medical Center in Sacramento, CA; 9Gilead Sciences, Foster City, CA; 10Fundacion De Investigacion San Juan, PR, 11Johns Hopkins University, Baltimore, MD, USA
CROI
webcast:
http://www.croiwebcasts.org/console/player/22172?mediaType=slideVideo&
|
| |
|
|
|
|
|
